Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.

Kirane A, Toombs JE, Ostapoff K, Carbon JG, Zaknoen S, Braunfeld J, Schwarz RE, Burrows FJ, Brekken RA.

Clin Cancer Res. 2012 Sep 15;18(18):5031-42. doi: 10.1158/1078-0432.CCR-12-0453. Epub 2012 Jul 24.

2.

CO2-formatics: how do proteins bind carbon dioxide?

Cundari TR, Wilson AK, Drummond ML, Gonzalez HE, Jorgensen KR, Payne S, Braunfeld J, De Jesus M, Johnson VM.

J Chem Inf Model. 2009 Sep;49(9):2111-5. doi: 10.1021/ci9002377.

PMID:
19705826

Supplemental Content

Loading ...
Support Center